Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2600118393Phase 2Completed
Phase 2, randomised trial of esmolol in postoperative pain (2 arms), sponsored by Wuxi People's Hospital. Primary endpoint: Changes in postoperative pain. Started Feb 2026; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2600118393.